KM
Kevin Patrick Moran
SVP, CFO & Treasurer

Kevin Patrick Moran insider trades: Vanda Pharmaceuticals (VNDA) stock buys and sales

SVP, CFO & Treasurer, Vanda Pharmaceuticals Last trade Mar 2, 2026 19 Form 4 filings
$351K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2021
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Kevin reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 2, 2026VNDA↓ Sell$351K
Feb 21, 2025VNDA↑ Buy$9K
Jul 29, 2024VNDA↓ Sell$13K
Mar 5, 2024VNDA↓ Sell$63K
Jul 28, 2023VNDA↓ Sell$14K
Jun 15, 2023VNDA↓ Sell$101K
Mar 3, 2023VNDA↓ Sell$87K
Dec 6, 2022VNDA↓ Sell$51K
Jul 28, 2022VNDA↓ Sell$25K
Mar 2, 2022VNDA↓ Sell$139K
Jul 28, 2021VNDA↓ Sell$41K
Mar 2, 2021VNDA↓ Sell$172K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other VNDA insiders

Open-market trades in the last 12 months

About Kevin Patrick Moran's insider trades

Kevin Patrick Moran is SVP, CFO & Treasurer at Vanda Pharmaceuticals (VNDA). Since Mar 2, 2021, Kevin has reported 1 open-market purchase worth $9K and 11 sales worth $1.1M on SEC Form 4. In the last 12 months: 1 sale ($351K).

Their filings also include grants and awards (7 filings), shares withheld for taxes (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VNDA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.